科技制造持续走热，芯擎科技完成超10亿元新融资

Group 1 - The technology and manufacturing sectors remain the primary focus of investment, with artificial intelligence and aerospace being particularly attractive to capital [1][3] - Hubei Chipking Technology Co., Ltd. completed a Series B financing round exceeding 1 billion RMB, while Dream Sky Technology (Suzhou) Co., Ltd. announced over 100 million RMB in cumulative Pre-A++ and strategic financing [1][23][44] - In the healthcare sector, Yingshi Biotechnology (Nanjing) Co., Ltd. secured over 34 million USD in Series C financing, led by Rehabilitation Capital [1][12] Group 2 - A total of 34 financing events occurred in the domestic primary market from August 18 to August 24, with 27 disclosing amounts totaling approximately 4.486 billion RMB [1][2] - The chip sector saw 4 financing rounds totaling 1.24 billion RMB, while the artificial intelligence sector had 3 rounds with disclosed amounts exceeding 59 million RMB [3][4] - Jiangsu Province, Beijing, and Shanghai were the most active regions, completing 12, 6, and 5 financing rounds respectively [5][6] Group 3 - Qiming Venture Partners and Yunze Capital were notably active, each completing 2 financing rounds primarily in the healthcare and technology sectors [6][7] - Beijing Huimei Cloud Technology Co., Ltd. raised nearly 200 million RMB, with funding from Shanghai Science and Technology Innovation Fund and Zhongding Capital [7][8] - Other companies like Zhitong Technology and Kegong Biotechnology also completed significant financing rounds, focusing on innovative medical and technological solutions [8][9][10]